Online first
Letter to the Editor
Published online: 2024-08-12
An Inpatient Metastatic Spine Neoplasm Score for assessing the appropriate modality of radiation therapy intervention
Abstract
Not required.
Keywords: metastatic spine diseaseinpatientprognosisstereotactic body radiation therapyexternal beam radiation therapy
References
- Sahgal A, Myrehaug SD, Siva S, et al. trial investigators. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. Lancet Oncol. 2021; 22(7): 1023–1033.
- Ryu S, Deshmukh S, Timmerman RD, et al. Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. JAMA Oncol. 2023; 9(6): 800–807.
- Pan H, Rose BS, Simpson DR, et al. A survey of stereotactic body radiotherapy use in the United States. Cancer. 2011; 117(19): 4566–4572.
- McClelland S, Kim E, Passias PG, et al. Spinal stereotactic body radiotherapy in the United States: A decade-long nationwide analysis of patient demographics, practice patterns, and trends over time. J Clin Neurosci. 2017; 46: 109–112.
- Zeng KL, Myrehaug S, Soliman H, et al. Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys. 2022; 114(2): 293–300.
- McClelland S3, Sun Y, Spratt DE, et al. Spine Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic Neoplasms (SPORTSMEN): a randomized phase II study protocol. Rep Pract Oncol Radiother. 2023; 28(3): 379–388.